Skip to main content
Top
Published in: Critical Care 5/2014

Open Access 01-10-2014 | Commentary

Beyond the evidence: treating pulmonary hypertension in the intensive care unit

Authors: Seth R Bauer, Adriano R Tonelli

Published in: Critical Care | Issue 5/2014

Login to get access

Abstract

Most patients with pulmonary arterial hypertension succumb to their disease in the ICU; however, limited evidence-based information exists to guide treatment in those that present with advanced right ventricular failure. Critical care physicians should be aware of the complexities of the treatment of patients with pulmonary arterial hypertension and should develop a strategy for their care. Current management is based on the pathophysiology of the disease and involves a multidisciplinary team supported by institutional polices directed at optimizing patient safety.
Literature
1.
go back to reference Muzevich KM, Chohan H, Grinnan DC: Management of pulmonary vasodilator therapy in patients with pulmonary arterial hypertension during critical illness. Crit Care. 2014, 18: 523-10.1186/s13054-014-0523-z.CrossRef Muzevich KM, Chohan H, Grinnan DC: Management of pulmonary vasodilator therapy in patients with pulmonary arterial hypertension during critical illness. Crit Care. 2014, 18: 523-10.1186/s13054-014-0523-z.CrossRef
2.
go back to reference Tonelli AR, Arelli V, Minai OA, Newman J, Bair N, Heresi GA, Dweik RA: Causes and circumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013, 188: 365-369. 10.1164/rccm.201209-1640OC.CrossRef Tonelli AR, Arelli V, Minai OA, Newman J, Bair N, Heresi GA, Dweik RA: Causes and circumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013, 188: 365-369. 10.1164/rccm.201209-1640OC.CrossRef
3.
go back to reference Tonelli AR, Zein J, Ioannidis JP: Geometry of the randomized evidence for treatments of pulmonary hypertension. Cardiovasc Ther. 2013, 31: e138-e146. 10.1111/1755-5922.12050.CrossRef Tonelli AR, Zein J, Ioannidis JP: Geometry of the randomized evidence for treatments of pulmonary hypertension. Cardiovasc Ther. 2013, 31: e138-e146. 10.1111/1755-5922.12050.CrossRef
4.
go back to reference Galie N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, Klepetko W, McGoon MD, McLaughlin VV, Preston IR, Rubin LJ, Sandoval J, Seeger W, Keogh A: Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol. 2013, 62: D60-D72. 10.1016/j.jacc.2013.10.031.CrossRef Galie N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, Klepetko W, McGoon MD, McLaughlin VV, Preston IR, Rubin LJ, Sandoval J, Seeger W, Keogh A: Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol. 2013, 62: D60-D72. 10.1016/j.jacc.2013.10.031.CrossRef
5.
go back to reference Rubin LJ: Endothelin receptor antagonists for the treatment of pulmonary artery hypertension. Life Sci. 2012, 91: 517-521. 10.1016/j.lfs.2012.07.033.CrossRef Rubin LJ: Endothelin receptor antagonists for the treatment of pulmonary artery hypertension. Life Sci. 2012, 91: 517-521. 10.1016/j.lfs.2012.07.033.CrossRef
6.
go back to reference Palmer SM, Robinson LJ, Wang A, Gossage JR, Bashore T, Tapson VF: Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Chest. 1998, 113: 237-240. 10.1378/chest.113.1.237.CrossRef Palmer SM, Robinson LJ, Wang A, Gossage JR, Bashore T, Tapson VF: Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Chest. 1998, 113: 237-240. 10.1378/chest.113.1.237.CrossRef
7.
go back to reference Tonelli AR, Minai OA: Perioperative management in patients with pulmonary hypertension. Annals Thoracic Med. 2014, 9: S98-S107. 10.4103/1817-1737.134048.CrossRef Tonelli AR, Minai OA: Perioperative management in patients with pulmonary hypertension. Annals Thoracic Med. 2014, 9: S98-S107. 10.4103/1817-1737.134048.CrossRef
8.
go back to reference Alkukhun L, Bair ND, Dweik RA, Tonelli AR: Subcutaneous to intravenous prostacyclin analog transition in pulmonary hypertension. J Cardiovasc Pharmacol. 2014, 63: 4-8. 10.1097/FJC.0000000000000018.CrossRef Alkukhun L, Bair ND, Dweik RA, Tonelli AR: Subcutaneous to intravenous prostacyclin analog transition in pulmonary hypertension. J Cardiovasc Pharmacol. 2014, 63: 4-8. 10.1097/FJC.0000000000000018.CrossRef
9.
go back to reference Cheng JW, Tonelli AR, Pettersson G, Krasuski RA: Pharmacologic management of perioperative pulmonary hypertension. J Cardiovasc Pharmacol. 2014, 63: 375-384. 10.1097/FJC.0000000000000050.CrossRef Cheng JW, Tonelli AR, Pettersson G, Krasuski RA: Pharmacologic management of perioperative pulmonary hypertension. J Cardiovasc Pharmacol. 2014, 63: 375-384. 10.1097/FJC.0000000000000050.CrossRef
10.
go back to reference Dzierba AL, Abel EE, Buckley MS, Lat I: A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndrome. Pharmacotherapy. 2014, 34: 279-290. 10.1002/phar.1365.CrossRef Dzierba AL, Abel EE, Buckley MS, Lat I: A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndrome. Pharmacotherapy. 2014, 34: 279-290. 10.1002/phar.1365.CrossRef
11.
go back to reference Siobal M: Aerosolized prostacyclins. Respir Care. 2004, 49: 640-652. Siobal M: Aerosolized prostacyclins. Respir Care. 2004, 49: 640-652.
12.
go back to reference Rich JD, Glassner C, Wade M, Coslet S, Arneson C, Doran A, Gomberg-Maitland M: The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension. Chest. 2012, 141: 36-42. 10.1378/chest.11-0245.CrossRef Rich JD, Glassner C, Wade M, Coslet S, Arneson C, Doran A, Gomberg-Maitland M: The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension. Chest. 2012, 141: 36-42. 10.1378/chest.11-0245.CrossRef
13.
go back to reference Kallen AJ, Lederman E, Balaji A, Trevino I, Petersen EE, Shoulson R, Saiman L, Horn EM, Gomberg-Maitland M, Barst RJ, Srinivasan A: Bloodstream infections in patients given treatment with intravenous prostanoids. Infect Control Hosp Epidemiol. 2008, 29: 342-349. 10.1086/529552.CrossRef Kallen AJ, Lederman E, Balaji A, Trevino I, Petersen EE, Shoulson R, Saiman L, Horn EM, Gomberg-Maitland M, Barst RJ, Srinivasan A: Bloodstream infections in patients given treatment with intravenous prostanoids. Infect Control Hosp Epidemiol. 2008, 29: 342-349. 10.1086/529552.CrossRef
14.
go back to reference Doran AK, Ivy DD, Barst RJ, Hill N, Murali S, Benza RL: Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension. Int J Clin Pract Suppl. 2008, 160: 5-9. 10.1111/j.1742-1241.2008.01811.x.CrossRef Doran AK, Ivy DD, Barst RJ, Hill N, Murali S, Benza RL: Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension. Int J Clin Pract Suppl. 2008, 160: 5-9. 10.1111/j.1742-1241.2008.01811.x.CrossRef
Metadata
Title
Beyond the evidence: treating pulmonary hypertension in the intensive care unit
Authors
Seth R Bauer
Adriano R Tonelli
Publication date
01-10-2014
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2014
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-014-0524-y

Other articles of this Issue 5/2014

Critical Care 5/2014 Go to the issue